132 results on '"Seferovic, Petar M"'
Search Results
2. Haemodynamic determinants of quality of life in chronic heart failure
3. Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry.
4. Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy
5. Burden of Heart Failure Signs and Symptoms, Prognosis, and Response to Therapy: The PARAGON-HF Trial
6. Sacubitril/valsartan for the treatment of non‐obstructive hypertrophic cardiomyopathy: An open label randomized controlled trial (SILICOFCM).
7. Early Unplanned Readmissions After Admission to Hospital With Heart Failure
8. Cardio‐renal‐metabolic disease in primary care setting.
9. Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification
10. Adverse cardiovascular outcomes in atrial fibrillation: Validation of the new 2MACE risk score
11. Telerehabilitation in heart failure patients: The evidence and the pitfalls
12. Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure
13. Exercise programs for LVAD supported patients: A snapshot from the ESC affiliated countries
14. Mineralocorticoid receptor antagonists, a class beyond spironolactone — Focus on the special pharmacologic properties of eplerenone
15. Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes
16. Effect of Left Ventricular Assist Device Implantation and Heart Transplantation on Habitual Physical Activity and Quality of Life
17. Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry.
18. Estimation of infarct size using transthoracic Doppler echocardiographic measurement of coronary flow reserve in infarct related and reference coronary artery
19. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases
20. Feasibility of the cardiac output response to stress test in suspected heart failure patients.
21. Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine – short version
22. Structural myocardial alterations in diabetes and hypertension: the role of galectin-3
23. The role of glycemia in acute heart failure patients
24. EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM
25. Renal effects of ularitide in patients with decompensated heart failure
26. Complex Angioplasty up to Chronic Total Occlusion*
27. Management of Pericardial Effusion: The Role of Echocardiography in Establishing the Indications and the Selection of the Approach for Drainage
28. Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)
29. New Directions in Diagnosis and Treatment of Pericardial Disease A Project of the Taskforce on Pericardial Disease of the World Heart Federation: A Project of the Taskforce on Pericardial Disease of the World Heart Federation
30. Flexible Percutaneous Pericardioscopy: Inherent Drawbacks and Recent Advances
31. Arrhythmias in Acute Pericarditis An Endomyocardial Biopsy Study: An Endomyocardial Biopsy Study
32. Intrapericardial Treatment of Autoreactive Myocarditis with Triamcinolon Successful Administration in Patients with Minimal Pericardial Effusion: Successful Administration in Patients with Minimal Pericardial Effusion
33. Relationship between peak cardiac pumping capability and selected exercise-derived prognostic indicators in patients treated with left ventricular assist devices
34. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy
35. Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry.
36. Haemodynamic and clinical effects of ularitide in decompensated heart failure
37. Contrast-induced nephropathy in a patient with type 2 diabetes and coronary artery disease: a case report.
38. Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: the ESC EORP Cardiomyopathy/Myocarditis Registry.
39. Insights into heart failure hospitalizations, management, and services during and beyond COVID‐19.
40. ESC/HFA Quality of Care Centres: the ultimate frontier in unifying heart failure management.
41. Integration of a palliative approach into heart failure care: a European Society of Cardiology Heart Failure Association position paper.
42. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry.
43. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry.
44. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology.
45. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.
46. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations.
47. NT‐proBNP is a weak indicator of cardiac function and haemodynamic response to exercise in chronic heart failure.
48. The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology.
49. Exercise training in patients with ventricular assist devices: a review of the evidence and practical advice. A position paper from the Committee on Exercise Physiology and Training and the Committee of Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology.
50. Застосування діуретиків при застійній серцевій недостатності: офіційна заява Асоціації серцевої недостатності Європейського товариства кардіологів
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.